scholarly journals Molecular Expression Analysis of Restrictive Receptor for Interleukin 13, a Brain Tumor-associated Cancer/Testis Antigen

2000 ◽  
Vol 6 (5) ◽  
pp. 440-449 ◽  
Author(s):  
Waldemar Debinski ◽  
Denise M. Gibo
2014 ◽  
Vol 133 ◽  
pp. 95
Author(s):  
A.E. Garcia-Soto ◽  
J.A. Lucci ◽  
E. Podack ◽  
T. Schreiber ◽  
E.D. Schroeder

Pathology ◽  
2012 ◽  
Vol 44 ◽  
pp. S109
Author(s):  
S. Deb ◽  
F.J. Chionh ◽  
A. Chakrabarti ◽  
J. Seah ◽  
J.S. Cebon ◽  
...  

2011 ◽  
Vol 22 (1) ◽  
pp. 98-103 ◽  
Author(s):  
G. Curigliano ◽  
G. Viale ◽  
M. Ghioni ◽  
A.A. Jungbluth ◽  
V. Bagnardi ◽  
...  

2021 ◽  
Vol 18 (10) ◽  
pp. 3832-3842
Author(s):  
Priyanka Verma ◽  
Saikat Biswas ◽  
Nitin Yadav ◽  
Anjali Khatri ◽  
Hamda Siddiqui ◽  
...  

2002 ◽  
Vol 98 (4) ◽  
pp. 485-492 ◽  
Author(s):  
Matthew J. Scanlan ◽  
Claudia M. Gordon ◽  
Barbara Williamson ◽  
Sang-Yull Lee ◽  
Yao-Tseng Chen ◽  
...  

2011 ◽  
Vol 286 (31) ◽  
pp. 27378-27388 ◽  
Author(s):  
Natsuki Kosaka-Suzuki ◽  
Teruhiko Suzuki ◽  
Elena M. Pugacheva ◽  
Alexander A. Vostrov ◽  
Herbert C. Morse ◽  
...  

2020 ◽  
Vol 15 (4) ◽  
pp. 29-37
Author(s):  
E. A. Makunina

Group of tumor-associated antigens, which is normally expressed in placental cells and testicular germ cells, is called cancer-testis antigens. To date, more than 40 gene families have been identified that encode cancer-testis antigens, and their expression has been studied in many types of malignant diseases. It is assumed that the expression of cancer-testis antigens can contribute to the development of the tumor transformation process, including hematological diseases. Of particular interest in the pathogenesis of multiple myeloma is the MAGE-C1/CT7 antigen, the expression of which is most often detected in this case. According to data published by various authors, the expression of MAGEC1 in multiple myeloma can be considered as an additional marker of a poor disease prognosis, represent the effectiveness of chemotherapy approaches, and, possibly, be an earlier predictor of relapse or progression.


Sign in / Sign up

Export Citation Format

Share Document